Foslinanib

Foslinanib (TRX-818) is an orally bioavailable agent with potential antineoplastic and anti-vasculogenic mimicry (VM) activities.

1256037-60-1

≥ 2 years

>98% (HPLC)

365.253

C16H13FNO6P

Research use only, not for human use.

Other Targets

Curated Selection

Explore Other Products

Discover premium biology products from our extensive collection of 20M+ items

Y158397 100 µL

Ask

38622014 1.0 µg DNA

Ask

bsm-52019R-PerCP 100 µL

Ask

FAB6169F 100 Tests

Ask

TA807002BM 100 µL

Ask